# Analysis of EGFR signaling pathway; miRNAs and inflammatory biomarkers in a high-risk oral cancer population in Pakistan - An exploratory study

**Authors:** Namrah Anwar, Shahid Pervez, Tariq Moatter, Mitchell Stark, Qurratulain Chundriger, Tazeen Saeed Ali, Sohail Awan, Annika Antonsson

PMC · DOI: 10.1371/journal.pone.0340264 · PLOS One · 2026-02-23

## TL;DR

This study explores how chewing habits and molecular factors like EGFR, COX-2, and miRNAs are linked to oral cancer in Pakistan.

## Contribution

The study identifies a significant association between chewing habits and EGFR/COX-2 expression in oral cancer patients from Pakistan.

## Key findings

- EGFR and COX-2 expression was significantly associated with chewing gutka.
- miR-222-3p was significantly downregulated in chewers expressing EGFR, NFκB, and COX-2.
- HR-HPV positivity was not correlated with miRNA expression.

## Abstract

Oral cancer has high morbidity rates in the Asian region, specifically Pakistan. However, little insight is available regarding the molecular pathogenesis and inflammatory biomarkers of this preventable cancer. This study determined the association of EGFR, NFκB, COX-2, and miRNAs expression with the chewing habits and high-risk human papillomavirus (HR-HPV) infection in oral cancer patients. Formalin-fixed paraffin-embedded blocks (FFPE) (n = 50) were analyzed for transcriptional expression of EGFR, NFκB, and COX-2 by qPCR and COX-2 protein expression was checked by immunohistochemistry (IHC). Array profiling of ~2500 miRNAs was performed on nine samples, and five miRNAs were selected for validation from this profiling data. Appropriate statistical tests were applied to check the association of EGFR., NFκB, COX-2, and miRNAs with chewing and HR-HPV status, (p < 0.05 and 95% CI). Of the 50 samples, transcriptional expression of EGFR was observed in 13 (26%), NFκB in 11 (22%), and COX-2 in 17 (34%) samples, and the majority were chewers. EGFR and COX-2 expression was significantly associated with chewing gutka (the most carcinogenic form of chewing substance). A total of 281 miRNAs were dysregulated in miRNA profiling, and in validation, miR-222-3p was significantly downregulated in chewers expressing EGFR, NFκB, and COX-2 compared to non-chewers (p < 0.05). HR-HPV positivity was not correlated with miRNAs. This study suggests a significant association of chewing habits with EGFR and COX-2 expression. In addition, the molecular pathogenesis of OSCC suggests the substantial interplay of NFκB, COX-2, EGFR and miRNAs in chronic chewers, irrespective of HR-HPV involvement.

## Linked entities

- **Genes:** EGFR (epidermal growth factor receptor) [NCBI Gene 1956], NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790], COX2 (cytochrome c oxidase subunit II) [NCBI Gene 4513]
- **Proteins:** COX2 (cytochrome c oxidase subunit II)
- **Diseases:** oral cancer (MONDO:0023644)

## Full-text entities

- **Genes:** MIR1260A (microRNA 1260a) [NCBI Gene 100302236] {aka MIR1260, MIRN1260, hsa-mir-1260, hsa-mir-1260a, mir-1260a}, GDE1 (glycerophosphodiester phosphodiesterase 1) [NCBI Gene 51573] {aka 363E6.2, MIR16}, PI3K [NCBI Gene 107795370], MIR221 (microRNA 221) [NCBI Gene 407006] {aka MIRN221, miRNA221, mir-221}, RELB (RELB proto-oncogene, NF-kB subunit) [NCBI Gene 5971] {aka I-REL, IMD53, IREL, REL-B}, COX-2 [NCBI Gene 3205306], MIR15B (microRNA 15b) [NCBI Gene 406949] {aka MIRN15B, hsa-mir-15b, miR-15b}, MIR21 (microRNA 21) [NCBI Gene 406991] {aka MIRN21, hsa-mir-21, miR-21, miRNA21}, RELA (RELA proto-oncogene, NF-kB subunit) [NCBI Gene 5970] {aka AIF3BL3, CMCU, NFKB3, p65}, EGFR (epidermal growth factor receptor) [NCBI Gene 1956] {aka ERBB, ERBB1, ERRP, HER1, NISBD2, NNCIS}, MIR137 (microRNA 137) [NCBI Gene 406928] {aka MIRN137, miR-137}, MIR423 (microRNA 423) [NCBI Gene 494335] {aka MIRN423, hsa-mir-423, mir-423}, MIR20A (microRNA 20a) [NCBI Gene 406982] {aka C13orf25, MIR20, MIRH1, MIRHG1, MIRN20, MIRN20A}, MTOR (mechanistic target of rapamycin kinase) [NCBI Gene 2475] {aka FRAP, FRAP1, FRAP2, RAFT1, RAPT1, SKS}, MIR145 (microRNA 145) [NCBI Gene 406937] {aka MIRN145, miR-145, miRNA145}, REL (REL proto-oncogene, NF-kB subunit) [NCBI Gene 5966] {aka C-Rel, HIVEN86A, IMD92}, MIR191 (microRNA 191) [NCBI Gene 406966] {aka MIRN191, miR-191}, CHAF1A (chromatin assembly factor 1 subunit A) [NCBI Gene 10036] {aka CAF-1, CAF1, CAF1B, CAF1P150, P150}, MIRLET7I (microRNA let-7i) [NCBI Gene 406891] {aka LET7I, MIRNLET7I, hsa-let-7i, let-7i}, OAS3 (2'-5'-oligoadenylate synthetase 3) [NCBI Gene 4940] {aka p100, p100OAS}, MIR155 (microRNA 155) [NCBI Gene 406947] {aka MIRN155, miRNA155, mir-155}, MIR100 (microRNA 100) [NCBI Gene 406892] {aka MIRN100, miR-100}, ZHX2 (zinc fingers and homeoboxes 2) [NCBI Gene 22882] {aka AFR1, RAF}, MIR196B (microRNA 196b) [NCBI Gene 442920] {aka MIRN196B, miR-196b, miRNA196B}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, TXK (TXK tyrosine kinase) [NCBI Gene 7294] {aka BTKL, PSCTK5, PTK4, RLK, TKL}, EPHB2 (EPH receptor B2) [NCBI Gene 2048] {aka BDPLT22, CAPB, DRT, EK5, EPHT3, ERK}, MIR34B (microRNA 34b) [NCBI Gene 407041] {aka MIRN34B, miRNA34B, mir-34b}, MIR143 (microRNA 143) [NCBI Gene 406935] {aka MIRN143, mir-143}, MIR99A (microRNA 99a) [NCBI Gene 407055] {aka MIRN99A, mir-99a}, COX2 (cytochrome c oxidase subunit II) [NCBI Gene 4513] {aka COII, MTCO2}, MIR203A (microRNA 203a) [NCBI Gene 406986] {aka MIR203, MIRN203, hsa-mir-203a, miR-203, miRNA203, mir-203a}, MIR185 (microRNA 185) [NCBI Gene 406961] {aka MIRN185, miR-185}, MIR320A (microRNA 320a) [NCBI Gene 407037] {aka MIRN320, MIRN320A, hsa-mir-320a, mir-320a}, AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}, MIR106B (microRNA 106b) [NCBI Gene 406900] {aka MIRN106B, mir-106b}
- **Diseases:** bladder cancer (MESH:D001749), ovarian cancer (MESH:D010051), IBD (MESH:D015212), breast cancer (MESH:D001943), infection (MESH:D007239), colon cancer (MESH:D015179), carcinogenic (MESH:D011230), metastasis (MESH:D009362), cancer of the lip and oral cavity (MESH:D008048), NSCLC (MESH:D002289), HNSCC (MESH:D000077195), carcinogenesis (MESH:D063646), OC (MESH:D009062), gastric cancers (MESH:D013274), Cancer (MESH:D009369), lung cancer (MESH:D008175), pancreatic cancer (MESH:D010190), AN (MESH:D021184), malignant melanoma (MESH:D008545), prostate cancer (MESH:D011471), inflammation (MESH:D007249)
- **Chemicals:** ROS (MESH:D017382), alcohol (MESH:D000438), H&amp;E (MESH:D006371), BQ (-), water (MESH:D014867), BaP (MESH:D001564), paraffin (MESH:D010232)
- **Species:** Areca catechu (areca-nut, species) [taxon 184783], Homo sapiens (human, species) [taxon 9606], Nicotiana tabacum (American tobacco, species) [taxon 4097], Human papillomavirus (species) [taxon 10566], Mus musculus (house mouse, species) [taxon 10090]
- **Mutations:** - 1195G> a
- **Cell lines:** RNU48 — Mus musculus (Mouse), Hybridoma (CVCL_J728)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12928398/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12928398/full.md

## References

67 references — full list in the complete paper: https://tomesphere.com/paper/PMC12928398/full.md

---
Source: https://tomesphere.com/paper/PMC12928398